Sage Journals: Discover world-class research

Abstract

Women with hypertensive forms of pregnancy such as hemolysis–elevated liver enzymes–low platelet syndrome have increased circulating endothelin 1; however, the relationship between hypertension and endothelin 1 has not been studied. Using an animal model, we sought to determine whether there was an increased activation/dysfunction of endothelin 1, the effect of endothelin 1 receptor-A blockade on hypertension and other manifestations of hemolysis, elevated liver enzymes, and low platelets syndrome. On gestational day 12, timed-pregnant rats were infused with soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEndoglin; 4.7 and 7 µg/kg) via mini-osmotic pumps for 8 days. A subset of rats were treated with receptor-A antagonist (ABT-627, 5mg/kg) for 8 days. Rats with hemolysis-elevated liver enzymes-low platelet syndrome had significantly increased hypertension (P = .0001), circulating endothelin 1 (P = .03), and a significant 3.3- and 7.2-fold increase in preproendothelin messenger RNA (mRNA) expression in the placenta and liver (P = .01 and .04). Urinary protein:creatinine ratio was significantly increased in these animals (P = .0007), and circulating factors from these rats stimulated a significant increase in endothelial cell secretion of endothelin 1 (P = .001) in an in vitro assay. Blockade of the endothelin 1 receptor A significantly decreased hypertension (P = .001), circulating endothelin 1, and interleukin 17 (P = .004 and .003), placental preproendothelin mRNA expression (P = .016), and urinary protein:creatinine ratio (P = .007) in rats with hemolysis–elevated liver enzymes–low platelet syndrome. Blockade of the endothelin 1 receptor A significantly decreased hemolysis (P = .009), liver enzymes (P = .011), and significantly increased platelet levels (P = .03) and decreased circulating CD4+ and CD8+ T lymphocytes (P = .0004 and .0001) in rats infused with sFlt-1 and sEndoglin. These data support the hypothesis that endothelin 1 activation has a critical role in pathophysiology of as hemolysis–elevated liver enzymes–low platelet syndrome.

Keywords

endothelin hypertension HELLP syndrome hemolysis platelets

Get full access to this article

View all access options for this article.

References

Geary

. The HELLP syndrome. Br J Obstet Gynaecol. 1997;104(8):887–891.

Sibai

. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing? Am J Obstet Gynecol. 1990;162(2):311–316.

Abildgaard

Heimdal

. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol. 2013;166(2):117–123.

Wallace

Martin

Jr Tam Tam

. Seeking the mechanisms of action for corticosteroids in HELLP syndrome: SMASH study. Am J Obstet Gynecol. 2013;208(5):380.e1–e8.

Strand

Seufert

. Placenta-derived CD95 Ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome. Gastroenterology. 2004;126(3):849–858.

Bussen

Sutterlin

Steck

. Plasma endothelin and big endothelin levels in women with severe preeclampsia or HELLP-syndrome. Arch Gynecol Obstet. 1999;262(3-4):113–119.

Tranquilli

Landi

Corradetti

. Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome. Cytokine. 2007;40(2):82–88.

Lamarca

. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia. Minerva Ginecol. 2012;64(4):309–320.

Cai

Griendling

Harrison

. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24(9):471–478.

10.

Wallace

Novotny

Heath

. Hypertension in response to CD4+ T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol. 2012;303(2):R144–R149.

11.

Aggarwal

Chandel

Jain

Jha

. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. J Hum Hypertens. 2012;26(4):236–241.

12.

Granger

Abram

Stec

Chandler

LaMarca

. Endothelin, the kidney and hypertension. Curr Hypertens Rep. 2006;8(4):298–303.

13.

Lerman

Kubo

Tschumperlin

Burnett

. Plasma endothelin concentrations in humans with end-stage heart failure and after heart-transplantation. J Am Coll Cardiol. 1992;20(4):849–853.

14.

LaMarca

. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol. 2010;62(2):105–120.

15.

LaMarca

. Progress toward identifying potential markers for preeclampsia: a role of agonistic autoantibody to the angiotensin II type I receptor. Hypertension. 2010;55(2):236–237.

16.

Lamarca

Cornelius

Wallace

. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology. 2013;28(4):225–233.

17.

Lamarca

Reckelhoff

. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol. 2012;303(1):H1–H8.

18.

Tam Tam

Lamarca

Arany

. Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. Am J Hypertens. 2011;24(1):110–113.

19.

Benyo

Smarason

Redman

Sims

Conrad

. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001;86(6):2502–2512.

20.

Kupferminc

Peaceman

Wigton

Rehnberg

Socol

. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol. 1994;170(6):1752–1757.

21.

Wallace

Morris

Kyle

. Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome. Hypertens Pregnancy. 2014;33(1):41–54.

22.

Venkatesha

Toporsian

Lam

. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642–649.

23.

Maynard

Min

Merchan

. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.

24.

LaMarca

Cockrell

Sullivan

Bennett

Granger

. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension. 2005;46(1):82–86.

25.

Amaral

Kiprono

Cornelius

. Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type 1 receptor in response to elevated interleukin-6 during pregnancy. Am J Obstet Gynecol. 2014;211(2):158.e1–e6.

26.

Wallace

Cornelius

Scott

. CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia. Hypertension. 2014;64(5):1151–1158.

27.

Wallace

Richards

Dhillion

. CD4+ T Helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension. 2011;57(5):949–955.

28.

Wallace

Chatman

Porter

. Endothelin-1 is elevated in plasma and explants from patients suffering with uterine leiomyomas. Reprod Sci. 2014;21(9):1196–1205.

29.

Novotny

Wallace

Herse

. CD4+ T cells play a critical role in mediating hypertension in response to placental ischemia. J Hypertens. 2013;2:1–6.

30.

George

Cockrell

Adair

Granger

. Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol. 2010;299(6):R1629–R1633.

31.

Roberts

Edep

Goldfien

Taylor

. Sera from preeclamptic women specifically activate human umblical vein enodothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol. 1992;27(3-4):101–108.

32.

Roberts

LaMarca

Fournier

Bain

Cockrell

Granger

. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension. 2006;47(3):615–618.

33.

Pollock

Opgenorth

. ET_A receptor mediated responses to ET-1 in the rat kidney. Br J Pharmacol. 1994;111(3):729–732.

34.

Parrish

Murphy

Rutland

. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens. 2010;23(8):911–916.

35.

Tanaka

Yoshioka

Tatsumi

Kimura

Kasuya

. Endothelin regulates function of IL-17 producing T cell subset. Life Sci. 2014;118(2):244–247.

36.

Cornelius

Hogg

Scott

. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress and hypertension in response to placental ischemia during pregnancy. Hypertension. 2013;62(6):1068–1073.

37.

Cornelius

Wallace

Kiprono

Dhillion

Moseley

Lamarca

. Endothelin-1 is not a mechanism of IL-17 induced hypertension during pregnancy. Med J Obstet Gynecol. 2013;1(1):1–10.

38.

Dhillion

Wallace

Scott

. IL-17 mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2012;303(4):R353–R358.

39.

Murphy

LaMarca

Cockrell

Granger

. Role of Endothelin in Mediating Soluble fms-Like Tyrosine Kinase 1 Induced Hypertension in Pregnant Rats. Hypertension. 2010;55(2):394–398.

40.

Halim

Kanayama

Maehara

Takahashi

Terao

. HELLP syndrome-like biochemical parameters obtained with endothelin-1 injections in rabbits. Gynecol Obstet Invest. 1993;35(4):193–198.

41.

Bahde

Kapoor

Viswanathan

Spiegel

Gupta

. Endothelin-1 receptor A blocker Darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in rats. Hepatology. 2014;59(3):1107–1117.

42.

Shchekotova

Shchekotov

Bulatova

Roitman

. Diagnostic efficiency of laboratory tests determining the functional status of the endothelium in patients with chronic diffuse liver diseases. Klin Lab Diagn. 2009;(10):24–26.

43.

Feng

Zhu

Zheng

. Downregulation of endothelin-1 by somatostatin improves liver function of recipients undergoing adult-to-adult living donor liver transplantation. Chin Med J. 2010;123(15):1961–1966.

44.

Jeremy

Shukla

Wan

Murphy

Angelini

Yim

. The pathobiology of endothelin-1 in vein graft disease: Are ETA receptor antagonists the solution to prevent vein graft failure? Curr Vasc Pharmacol. 2005;3(4):315–323.

45.

Jagroop

Daskalopoulou

Mikhailidis

. Endothelin-1 and human platelets. Curr Vasc Pharmacol. 2005;3(4):393–399.

46.

Helset

Lindal

Olsen

Myklebust

Jorgensen

. Endothelin-1 causes sequential trapping of platelets and neutrophils in pulmonary microcirculation in rats. Am J Physiol. 1996;271(14 pt 1):L538–L546.

47.

Amraoui

Spijkers

Hassani Lahsionoui

. SFlt-1 elevates blood pressure by augmenting endothelin-1 mediated vasoconstriction in mice. PLos One. 2014;9(3):e91897.

48.

Hagaman

Kim

. eNOS deficiency acts through endothelin to aggravate sFlt-1 induced pre-eclampsia like phenotype. J Am Soc Nephrol. 2012;23(4):652–660.

49.

Shen

Wei

Snowise

. Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: a mechanism by which the placenta communicates with the maternal endothelium. Placenta. 2014;35(10):839–847.

50.

Lau

Barrett

Guild

Chamley

. Necrotic trophoblast decris increases blood pressure during pregnancy. J Reprod Immunol. 2013;97(2):175–182.

51.

LaMarca

Bennett

Alexander

Cockrell

Granger

. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension. 2005;46(4):1022–1025.

52.

Sedeek

Gilbert

LaMarca

. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens. 2008;21(10):1152–1156.

53.

Sanchez-Aranguren

Prada

Riano-Medina

Lopez

. Endothelial dysfunction and preeclampsia: a role of oxidative stress. Front Physiol. 2014;5:1–11.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.11 MB

0.06 MB

Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1

Abstract

Keywords

Get full access to this article

References

Supplementary Material